4.0789

2.77% 0.1089

Sana Biotechnology Inc (SANA)

Overview News Price History Option Chain Financials Why SANA Down? Discussions Forecast

Sana Biotechnology Inc stock is traded at $4.0789, with a volume of 2.15M. It is up +2.77% in the last 24 hours and up +52.24% over the past month. Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.

Previous Close:

$3.97

Open:

$3.98

24h Volume:

2.15M

Relative Volume:

0.56

Market Cap:

$1.13B

Revenue:

Net Income/Loss:

$-241.99M

P/E Ratio:

-4.3443

EPS:

-0.9389

Net Cash Flow:

$-133.64M

1W Performance:

+16.91%

1M Performance:

+52.24%

6M Performance:

-13.74%

1Y Performance:

+31.61%

1-Day Range:

$3.73

$4.1201

1-Week Range:

$3.435

$4.1201

52-Week Range:

$2.61

$6.55

Sana Biotechnology Inc Stock (SANA) Company Profile

Name

Sana Biotechnology Inc

Sector

Healthcare (1100)

Industry

Biotechnology (615)

Phone

(206) 701-7914

Address

188 EAST BLAINE STREET, SUITE 350, SEATTLE

Employee

142

Twitter

Next Earnings Date

2026-08-10

Latest SEC Filings

SANA's Discussions on Twitter

Compare SANA vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SANA Sana Biotechnology Inc	4.075	1.12B	0	-241.99M	-133.64M	-0.9389
VRTX Vertex Pharmaceuticals Inc	524.81	134.02B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	672.55	68.59B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	920.71	58.44B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	320.29	41.76B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	192.06	40.23B	742.00K	-1.37B	-1.07B	-7.0731

Sana Biotechnology Inc Stock (SANA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-24-25	Initiated	Wedbush	Outperform
Jul-03-25	Resumed	Morgan Stanley	Overweight
Mar-18-25	Upgrade	Citizens JMP	Mkt Perform → Mkt Outperform
Mar-14-25	Initiated	Jefferies	Buy
Jan-08-25	Upgrade	TD Cowen	Hold → Buy
Nov-05-24	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
Jun-26-24	Initiated	Rodman & Renshaw	Buy
Jan-16-24	Upgrade	H.C. Wainwright	Neutral → Buy
Sep-25-23	Initiated	JMP Securities	Mkt Outperform
Sep-05-23	Initiated	Citigroup	Buy
Aug-14-23	Initiated	TD Cowen	Market Perform
May-02-23	Initiated	H.C. Wainwright	Neutral
Mar-01-21	Initiated	BofA Securities	Buy
Mar-01-21	Initiated	Goldman	Neutral
Mar-01-21	Initiated	JP Morgan	Neutral
Mar-01-21	Initiated	Morgan Stanley	Overweight

View All

Sana Biotechnology Inc Stock (SANA) Latest News

Jul 03, 2026

SANA Should I Buy - Intellectia AI

Jul 03, 2026

Jul 01, 2026

Sana to show first-in-human islet transplant data without immunosuppression - Stock Titan

Jul 01, 2026

Citizens reiterates Sana Biotechnology stock rating on IND filing By Investing.com - Investing.com Canada

Jul 01, 2026

Will Removal From Russell Value Benchmarks Change Sana Biotechnology's (SANA) Institutional Investor Narrative? - simplywall.st

Jul 01, 2026

Jun 29, 2026

Sana Biotechnology, Inc.(NasdaqGS:SANA) dropped from Russell Small Cap Comp Value Benchmark - marketscreener.com

Jun 29, 2026

Sana Biotechnology, Inc.(NasdaqGS: SANA) dropped from Russell 3000 Value Benchmark - marketscreener.com

Jun 29, 2026

Jun 28, 2026

Sana Biotechnology, Inc.(NasdaqGS: SANA) dropped from Russell 3000E Value Benchmark - marketscreener.com

Jun 28, 2026

Jun 27, 2026

Join Class Action to Recover Losses from Sana Biotechnology, Inc - The National Law Review

Jun 27, 2026

Lost Money on Sana Biotechnology, Inc. (SANA)? Contact Levi & Korsinsky to Join Class Action Before May 20, 2025 - The National Law Review

Jun 27, 2026

Jun 26, 2026

Enterprise value to EBIT forward of Sana Biotechnology, Inc. – NASDAQ:SANA - TradingView

Jun 26, 2026